Upload
arif-ahammed-p
View
233
Download
0
Embed Size (px)
Citation preview
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
1/47
1
1
Introduction to CBC and BloodSmear Interpretation
Introduction to CBC and BloodIntroduction to CBC and BloodSmear InterpretationSmear Interpretation
Thanyaphong Na Nakorn, MD, PhD
Division of HematologyDepartment of MedicineChulalongkorn University
Thanyaphong Na Nakorn, MD, PhDThanyaphong Na Nakorn, MD, PhD
Division of HematologyDivision of HematologyDepartment of MedicineDepartment of Medicine
Chulalongkorn UniversityChulalongkorn University
2
Complete blood countComplete blood countComplete blood count
z The most common test used in clinical medicinez Determine type and severity of blood cell
abnormalitiesz Nowadays, CBC is fully automated and highly
reproducible.z Correct interpretation of automated CBC can
reduce rate of unnecessary blood smearexamination
z Provide useful information for provisionaldiagnosis of RBC and WBC diseases
zz The most common test used in clinical medicineThe most common test used in clinical medicinezz Determine type and severity of blood cellDetermine type and severity of blood cell
abnormalitiesabnormalitieszz Nowadays, CBC is fully automated and highlyNowadays, CBC is fully automated and highly
reproducible.reproducible.zz Correct interpretation of automated CBC canCorrect interpretation of automated CBC can
reduce rate of unnecessary blood smearreduce rate of unnecessary blood smearexaminationexamination
zz Provide useful information for provisionalProvide useful information for provisionaldiagnosis of RBC and WBC diseasesdiagnosis of RBC and WBC diseases
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
2/47
2
3
Component of automated CBCComponent of automated CBCComponent of automated CBC
z Blood count basic parameters: Hb, Hct,RBC, WBC, platlet.
z Red cell indices: MCV, MCH, MCHC, RDWz WBC differentialsz Cytogram or Scattergramz Reticulocyte count
zz Blood count basic parameters:Blood count basic parameters: HbHb,, HctHct,,RBC, WBC,RBC, WBC, platletplatlet..
zz Red cell indices: MCV, MCH, MCHC, RDWRed cell indices: MCV, MCH, MCHC, RDW
zz WBC differentialsWBC differentialszz CytogramCytogram oror ScattergramScattergram
zz ReticulocyteReticulocyte countcount
4
Basic principles of automated bloodBasic principles of automated bloodcell analyzercell analyzer
zz Electrical impedance:Electrical impedance:
Coulter CounterCoulter Counter ,, CellCell--DynDyn
zz
Optical impedance and light scatter:Optical impedance and light scatter:TechniconTechnicon--H seriesH series
zz VCS (volume, conductivity, light scatter) technologyVCS (volume, conductivity, light scatter) technology
BeckmanBeckman--Coulter VCS, MAXM,Coulter VCS, MAXM, STKSSTKS
nidistrega.info
http://www.manidistrega.info/http://www.manidistrega.info/7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
3/47
3
5
Cell count and size can be measured byelectrical impedance
Cell count and size can be measured byCell count and size can be measured byelectrical impedanceelectrical impedance
Coulter TechnologyCoulter TechnologyCoulter Technology
J.Paul RobinsonJ.Paul Robinson
6
Direction of flowDirection of flow
The Bernoulli EffectThe Bernoulli Effect
Velocity GradientVelocity Gradient
Viscous drag along walls.Viscous drag along walls.
Lower pressureLower pressure
Particles move to low pressure areaParticles move to low pressure area
Laminar Coaxial FlowLaminar Coaxial FlowSheath fluidSheath fluid
Hydrodynamic FocusingHydrodynamic Focusing
nidistrega.info
http://www.manidistrega.info/http://www.manidistrega.info/7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
4/47
4
7
Technicon TechnologyTechniconTechnicon TechnologyTechnology
8
VCS TechnologyVCS TechnologyVCS Technology
nidistrega.info
http://www.manidistrega.info/http://www.manidistrega.info/7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
5/47
5
9
Impedance, laser light scatterImpedance, laser light scatterCellCell DynDyn 4000 (Abbott)4000 (Abbott)
CytochemistryCytochemistry, flow technology, flow technology((reticulocytereticulocyte analysis)analysis)
AdviaAdvia 120 (Bayer)120 (Bayer)
CytochemistryCytochemistry, flow technology, flow technology
((reticulocytereticulocyte analysis)analysis)
TechniconTechnicon HH--3 (Bayer)3 (Bayer)
Impedance, light absorption (halogenImpedance, light absorption (halogenlight source)light source)
CobasCobas Argos 5Argos 5--diff (Roche)diff (Roche)
Direct current (resistance to cellDirect current (resistance to cellvolume); radiovolume); radio--frequency (cell density,frequency (cell density,size)size)
SysmexSysmex SESE--90009000
Impedance, flowImpedance, flow cytometrycytometry,,conductivity, laser light scatterconductivity, laser light scatter((reticulocytereticulocyte analysis)analysis)
Coulter GENCoulter GEN--SS
Impedance, conductivity, laserImpedance, conductivity, lasertechnologytechnology
Coulter STKSCoulter STKSMethodology featuresMethodology featuresInstrumentInstrument
10
Red cell parametersRed cell parametersRed cell parameters
z Direct Measurement Erythrocyte Concentration (RBC) x 106/ml Mean Corpuscular Volume (MCV) Femtolitre (fl) Hemoglobin (Hb) Gram/decilitre (g/dl)
z Indirect Measurement Hematocrit (Hct) = RBC x MCV/10 % Mean Corpuscular Hemoglobin (MCH) = HB x 10 / RBC (pg) Mean Corpuscular Hemoglobin Concentration (MCHC)
= Hb/Hct x 100 (g/dl) Red Cell Distribution Width (RDW) %
zz Direct MeasurementDirect Measurement Erythrocyte Concentration (Erythrocyte Concentration (RBCRBC)) x 10x 1066/ml/ml Mean Corpuscular Volume (Mean Corpuscular Volume (MCVMCV)) FemtolitreFemtolitre (fl)(fl) Hemoglobin (Hemoglobin (HbHb)) Gram/Gram/decilitredecilitre (g/dl)(g/dl)
zz Indirect MeasurementIndirect Measurement HematocritHematocrit ((HctHct) = RBC x MCV/10) = RBC x MCV/10 %% Mean Corpuscular Hemoglobin (Mean Corpuscular Hemoglobin (MCHMCH) = HB x 10 / RBC (pg)) = HB x 10 / RBC (pg) Mean Corpuscular Hemoglobin Concentration (Mean Corpuscular Hemoglobin Concentration (MCHCMCHC))
== Hb/HctHb/Hct x 100x 100 (g/dl)(g/dl) Red Cell Distribution Width (Red Cell Distribution Width (RDWRDW)) %%
nidistrega.info
http://www.manidistrega.info/http://www.manidistrega.info/7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
6/47
6
11
RBC size and MCVRBC size and MCVRBC size and MCV
12
RRed Celled Cell DDistributionistribution WWidthidthRBC x 106/ml
75 80 85 90
20th
percentile 80th percentile
RDW
RDW =80th percentile - 20th percentile
80th percentile + 20th percentileX constant
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
7/47
7
13
WBC: three-part differentialsWBC: threeWBC: three--part differentialspart differentials
CellCell--DynDyn 1700CS1700CS
14
WBC: Five-part differentialsWBC: FiveWBC: Five--part differentialspart differentials
Neutrophil
Lymphocyte
Monocyte Eosinophil
Basophil
NeutrophilNeutrophil
LymphocyteLymphocyte
MonocyteMonocyte EosinophilEosinophil
BasophilBasophil
Coulter VCSCoulter VCS
lymphocyte
Monocyte
Baso
NEo
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
8/47
8
15
WBC: Six-part differentialsWBC: SixWBC: Six--part differentialspart differentials
Neutrophil
Lymphocyte
Monocyte
Eosinophil
Basophil
Large Unstained Cell
(LUC)
NeutrophilNeutrophil
LymphocyteLymphocyte
MonocyteMonocyte
EosinophilEosinophil
BasophilBasophil
Large Unstained CellLarge Unstained Cell
(LUC)(LUC)
TechniconTechnicon*H2*H2
PeroxidasePeroxidase channelchannel
16
WBC: Six-part differentialsWBC: SixWBC: Six--part differentialspart differentials
TechniconTechnicon*H2*H2
Basophil/lobularityBasophil/lobularity channelchannel
Additional parameters inTechnicon-H analyzer
1. Mean peroxidase activityindex (MPXI)
2. Lobularity Index (LI)
Additional parameters inAdditional parameters inTechniconTechnicon--H analyzerH analyzer
1.1. MeanMean peroxidaseperoxidase activityactivityindex (MPXI)index (MPXI)
2.2. LobularityLobularity Index (LI)Index (LI)
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
9/47
9
17
Platelet parametersPlatelet parametersPlatelet parameters
z Platelet count
z Mean Platelet Volume (MPV)
z Platelet Distribution Width (PDW)
z Plateletcrit (Pct)
zz Platelet countPlatelet count
zz Mean Platelet Volume (MPV)Mean Platelet Volume (MPV)
zz Platelet Distribution Width (PDW)Platelet Distribution Width (PDW)
zz PlateletcritPlateletcrit (Pct)(Pct)
18
Reticulocyte countReticulocyteReticulocyte countcount
z Reticulocyte = non-nucleated RBCwith polyribosomal RNA as stainedby supravital stain (new methyleneblue or brilliant cresyl blue)
z Polychromasia underestimatesreticulocytes
z Three methods of reticulocyteenumeration Manual count on slide per 1,000
RBC Automated CBC with
reticulocyte counter (CoulterVCS, Cell-Dyne 4000, Technicon-H3)
Flow cytometry with fluorescentdyes
zz ReticulocyteReticulocyte = non= non--nucleated RBCnucleated RBCwithwith polyribosomalpolyribosomal RNA as stainedRNA as stainedbyby supravitalsupravital stain (newstain (new methylenemethyleneblue or brilliantblue or brilliant cresylcresyl blue)blue)
zz PolychromasiaPolychromasia underestimatesunderestimates
reticulocytesreticulocyteszz Three methods ofThree methods of reticulocytereticulocyte
enumerationenumeration Manual count on slide per 1,000Manual count on slide per 1,000
RBCRBC Automated CBC withAutomated CBC with
reticulocytereticulocyte counter (Coultercounter (CoulterVCS, CellVCS, Cell--Dyne 4000, TechniconDyne 4000, Technicon--H3)H3)
FlowFlow cytometrycytometry with fluorescentwith fluorescentdyesdyes
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
10/47
10
19
Report from CoulterReport from CoulterReport from Coulter
20
Report from Technicon-HReport fromReport from TechniconTechnicon--HH
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
11/47
11
21
22
Clinical Utility of automated CBCClinical Utility of automated CBCClinical Utility of automated CBC
z Differential diagnosis of RBC disordersMicrocytic RBC
z Use WBC differential cytogram to guideWBC morphology and phenotypes
zz Differential diagnosis of RBC disordersDifferential diagnosis of RBC disorders MicrocyticMicrocytic RBCRBC
zz Use WBC differentialUse WBC differential cytogramcytogram to guideto guideWBC morphology and phenotypesWBC morphology and phenotypes
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
12/47
12
23
WBCWBC 5.005.00 x10x1033//LLRBCRBC 3.563.56 x10x1066//LLHbHb 6.06.0 g/dLg/dL
HCTHCT 21.021.0 %%
MCVMCV 59.059.0 fLfL
MCHMCH 17.017.0 pgpg
MCHCMCHC 28.828.8 g/dLg/dL
RDWRDW 19.419.4 %%
HDWHDW 4.024.02 g/dLg/dL
PLTPLT 427427 x10x1033//LL
What is your diagnosis?What is your diagnosis?What is your diagnosis?
24
Differential diagnosis of anemiausing MCV and RDW
Differential diagnosis of anemiaDifferential diagnosis of anemiausing MCV and RDWusing MCV and RDW
B12 deficiencyB12 deficiencyFolateFolate deficiencydeficiency
AIHAAIHADrugs: HU, ARV,Drugs: HU, ARV,
AZA, etc.AZA, etc.
Early or combinedEarly or combinednutritionalnutritionaldeficiencydeficiency
MyelodysplasiaMyelodysplasiaMyelophthisisMyelophthisisSickle cell anemia orSickle cell anemia or
HomozygousHomozygous HbCSHbCS
Iron deficiency anemiaIron deficiency anemiaThalassemiaThalassemia intermediaintermedia
SideroblasticSideroblastic anemiaanemiaSevere ACDSevere ACD
RBC fragmentationRBC fragmentationRDW >15RDW >15
AplasticAplastic anemiaanemia
MDSMDSMyelomaMyeloma
Liver diseaseLiver diseaseHyperthyroidismHyperthyroidism
ACDACD
HeterozygousHeterozygous HbSHbS,,HbCSHbCS,, HbEHbE, etc., etc.
HereditaryHereditaryspherocytosisspherocytosisAcute hemorrhageAcute hemorrhage
ThalassemiaThalassemia traittrait
HeterozygousHeterozygous HbEHbE,, HbCHbC,,etc.etc.
Anemia of chronicAnemia of chronicdisease (ACD)disease (ACD)
RDW
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
13/47
13
25
SatellitismSatellitism, clumping, clumpingWBC fragmentation, severeWBC fragmentation, severemicrocytosismicrocytosis,, cryoglobulinscryoglobulins
PlateletsPlatelets
ClottingClottingNucleated red cells, platelet clumps,Nucleated red cells, platelet clumps,unlysedunlysed red cells,red cells, cryoglobulinscryoglobulins
WBCsWBCsPost transfusionPost transfusionRDWRDW
WBC >50 000/mmWBC >50 000/mm33HyperlipidemiaHyperlipidemia, cold agglutinins, cold agglutininsMCHCMCHC
CryoglobulinsCryoglobulinsCold agglutinins, hyperglycemia,Cold agglutinins, hyperglycemia,WBC >50 000/mmWBC >50 000/mm33
MCVMCV
ClottingClottinghyperlipidemiahyperlipidemia,, hyperbilirubinemiahyperbilirubinemiaHbHb
ClottingClottingWBC >50 000/mmWBC >50 000/mm33RBCsRBCs
Spuriously increasedSpuriously increased Spuriously decreasedSpuriously decreasedParameterParameter
Factors known to cause spurious laboratoryFactors known to cause spurious laboratory
results in hematology analyzers.results in hematology analyzers.
26
Basic Principles for Blood SmearInterpretation
Basic Principles for Blood SmearBasic Principles for Blood SmearInterpretationInterpretation
z Assess quality of smears Specimen preparation & staining
z Estimate cell numbers RBC: evenly dispersed with minimalintercellular space
WBC: 10-20/LPF Platelets: 7-20/OF
z Determine predominant cell populationsz Carefully examine cellular morphology
zz Assess quality of smearsAssess quality of smears Specimen preparation & stainingSpecimen preparation & staining
zz Estimate cell numbersEstimate cell numbers
RBC: evenly dispersed with minimalRBC: evenly dispersed with minimalintercellular spaceintercellular space
WBC:WBC: 1010--20/LPF20/LPF Platelets: 7Platelets: 7--20/OF20/OF
zz Determine predominant cell populationsDetermine predominant cell populationszz Carefully examine cellular morphologyCarefully examine cellular morphology
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
14/47
14
27
RBC disordersRBC disordersRBC disordersz Hypochromic microcytic anemia
Iron deficiency anemia Thalassemia and hemoglobinopathy
z Macrocytic anemia Megaloblastic anemia Non-megaloblastic macrocytic anemia
z Hemolytic anemia Immune hemolytic anemia: AIHA, DHTR
Microangiopathic hemolytic anemia (MAHA) Red cell enzymopathies: G-6-PD deficiency RBC membrane defects: spherocytosis,
ovalocytosis, elliptocytosis, stomatocytosisz RBC inclusion bodies and parasites
zz HypochromicHypochromic microcyticmicrocytic anemiaanemia Iron deficiency anemiaIron deficiency anemia ThalassemiaThalassemia andand hemoglobinopathyhemoglobinopathy
zz MacrocyticMacrocytic anemiaanemia MegaloblasticMegaloblastic anemiaanemia NonNon--megaloblasticmegaloblastic macrocyticmacrocytic anemiaanemia
zz Hemolytic anemiaHemolytic anemia Immune hemolytic anemia: AIHA, DHTRImmune hemolytic anemia: AIHA, DHTR
MicroangiopathicMicroangiopathic hemolytic anemia (MAHA)hemolytic anemia (MAHA) Red cellRed cell enzymopathiesenzymopathies: G: G--66--PD deficiencyPD deficiency RBC membrane defects:RBC membrane defects: spherocytosisspherocytosis,,
ovalocytosisovalocytosis,, elliptocytosiselliptocytosis,, stomatocytosisstomatocytosiszz RBC inclusion bodies and parasitesRBC inclusion bodies and parasites
28
Area of blood film examinationArea of blood film examinationArea of blood film examination
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
15/47
15
29
RBC Size and MCVRBC Size and MCVRBC Size and MCV
30
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
16/47
16
31
32
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
17/47
17
33
34
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
18/47
18
35
36
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
19/47
19
37
38
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
20/47
20
39
40
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
21/47
21
41
42
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
22/47
22
43
44
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
23/47
23
45
46
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
24/47
24
47
48
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
25/47
25
49
50
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
26/47
26
51
52
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
27/47
27
53
54
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
28/47
28
55
56
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
29/47
29
57
58
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
30/47
30
59
60
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
31/47
31
61
62
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
32/47
32
63
64
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
33/47
33
65
66
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
34/47
34
67
WBC disordersWBC disordersWBC disordersz Leukopenia
with absolute neutropenia: bone marrow failure,agranulocytosis
with atypical lymphocytes: viral infection, chroniclymphoproliferative disorders
with immature myeloid cells: acute leukemia, MDSor myelopthisis
z Leukocytosis Reactive leukocytosis: leukemoid reaction Acute leukemia: AML vs. ALL Chronic myeloproliferative disorders Chronic lymphoproliferative disorders
z Leukoerythroblastosis
zz LeukopeniaLeukopenia
with absolutewith absolute neutropenianeutropenia: bone marrow failure,: bone marrow failure,agranulocytosisagranulocytosis
with atypical lymphocytes: viral infection, chronicwith atypical lymphocytes: viral infection, chroniclymphoproliferativelymphoproliferative disordersdisorders
with immature myeloid cells: acute leukemia, MDSwith immature myeloid cells: acute leukemia, MDSoror myelopthisismyelopthisis
zz LeukocytosisLeukocytosis
ReactiveReactive leukocytosisleukocytosis:: leukemoidleukemoid reactionreaction
Acute leukemia: AML vs. ALLAcute leukemia: AML vs. ALL
ChronicChronic myeloproliferativemyeloproliferative disordersdisorders
ChronicChronic lymphoproliferativelymphoproliferative disordersdisorders
zz LeukoerythroblastosisLeukoerythroblastosis
68
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
35/47
35
69
70
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
36/47
36
71
72
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
37/47
37
73
74
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
38/47
38
75
76
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
39/47
39
77
78
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
40/47
40
79
80
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
41/47
41
81
82
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
42/47
42
83
Platelet disordersPlatelet disordersPlatelet disorders
z Quantitative disorders Isolated thrombocytopenia: Immune vs. non-immune Thrombocytopenia associated with other hematologic
abnormalities Thrombocytosis
z Qualitative disorders Giant platelets (megathrombocytes)
Platelet inclusion or granule abnormality Bizarre in shape and size Megakaryocytes or megakaryoblasts
zz Quantitative disordersQuantitative disorders
Isolated thrombocytopenia: Immune vs. nonIsolated thrombocytopenia: Immune vs. non--immuneimmune
Thrombocytopenia associated with otherThrombocytopenia associated with other hematologichematologicabnormalitiesabnormalities
ThrombocytosisThrombocytosis
zz Qualitative disordersQualitative disorders
Giant platelets (Giant platelets (megathrombocytesmegathrombocytes))
Platelet inclusion or granule abnormalityPlatelet inclusion or granule abnormality Bizarre in shape and sizeBizarre in shape and size
MegakaryocytesMegakaryocytes oror megakaryoblastsmegakaryoblasts
84
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
43/47
43
85
86
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
44/47
44
87
88
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
45/47
45
89
90
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
46/47
46
91
92
7/27/2019 GOOD CBC PRINCIPLE,INTERPRETATION.pdf
47/47
93